Adjuvant chemotherapy of superficial transitional cell carcinoma: an E.O.R.T.C. randomized trail comparing doxorubicin hydrochloride, ethoglucid and TUR-alone

Prog Clin Biol Res. 1985:185B:135-42.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Carcinoma, Transitional Cell / drug therapy*
  • Carcinoma, Transitional Cell / pathology
  • Carcinoma, Transitional Cell / surgery
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Doxorubicin / administration & dosage
  • Doxorubicin / therapeutic use*
  • Ethers / therapeutic use*
  • Ethoglucid / administration & dosage
  • Ethoglucid / therapeutic use*
  • Humans
  • Neoplasm Recurrence, Local / drug therapy*
  • Random Allocation
  • Urinary Bladder Neoplasms / drug therapy*
  • Urinary Bladder Neoplasms / pathology
  • Urinary Bladder Neoplasms / surgery

Substances

  • Ethers
  • Ethoglucid
  • Doxorubicin